Updates on Antiphospholipid Syndrome
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 20 November 2024 | Viewed by 49
Special Issue Editor
2. Institut d'Investigacions Biomèdiques Pi I Sunyer (IDIBAPS), Barcelona, Spain
Interests: antiphospholipid syndrome; antiphospholipid antibodies; anticardiolipin antibodies; lupus anticoagulant; beta2-glycoprotein 1
Special Issue Information
Dear Colleagues,
Antiphospholipid syndrome (APS) is an immune system disorder that increases the risk of thrombosis and pregnancy morbidity. It must be suspected in particular in young patients with repeated thrombosis, especially in unusual sites and/or with multiple abortions in the absence of genetic and chromosomal abnormalities or preterm birth due to severe pre-eclampsia. Although the syndrome was first described more than 40 years ago, it is not yet clear what the etiology is of these antibody abnormalities, nor their exact pathophysiological characteristics. Moreover, although current standard treatments are effective in most cases, there is still a considerable number of patients that present the recurrence of clinical manifestations.
The aim of this Special Issue, which invites the submission of original papers and reviews, is to provide an updated overview of innovative advances in diagnostics, pharmacotherapy, and complications of APS that will aid in the accurate diagnosis and management of this devasting disease to prevent its deleterious consequences.
Dr. Giuseppe Barilaro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiphospholipid syndrome
- antiphospholipid antibodies
- beta2-glycoprotein 1
- systemic lupus erythematosus
- immunosuppressive therapy
- thrombosis
- diagnosis
- pre-eclampsia
- preterm birth
- fetal death
